BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 14519750)

  • 1. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?
    Choy H; Milas L
    J Natl Cancer Inst; 2003 Oct; 95(19):1440-52. PubMed ID: 14519750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.
    Gately S; Kerbel R
    Prog Exp Tumor Res; 2003; 37():179-92. PubMed ID: 12795055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
    Liao Z; Milas L; Komaki R; Stevens C; Cox JD
    Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.
    Nakata E; Mason KA; Hunter N; Husain A; Raju U; Liao Z; Ang KK; Milas L
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):369-75. PubMed ID: 14751505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
    Milas L
    Am J Clin Oncol; 2003 Aug; 26(4):S66-9. PubMed ID: 12902859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme.
    Milas L; Mason KA; Crane CH; Liao Z; Masferrer J
    Oncology (Williston Park); 2003 May; 17(5 Suppl 5):15-24. PubMed ID: 12800601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New chemotherapeutic agents: update of major chemoradiation trials in solid tumors.
    Curran WJ
    Oncology; 2002; 63 Suppl 2():29-38. PubMed ID: 12466642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
    Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
    Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2: a novel target for cancer chemotherapy?
    Dempke W; Rie C; Grothey A; Schmoll HJ
    J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
    Saha D; Pyo H; Choy H
    Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
    Masferrer JL; Leahy KM; Koki AT; Zweifel BS; Settle SL; Woerner BM; Edwards DA; Flickinger AG; Moore RJ; Seibert K
    Cancer Res; 2000 Mar; 60(5):1306-11. PubMed ID: 10728691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.
    Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC
    J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
    Davis TW; Hunter N; Trifan OC; Milas L; Masferrer JL
    Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
    Gallo O
    J Natl Cancer Inst; 2000 Feb; 92(4):346-7. PubMed ID: 10675387
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM; Ornberg RL; Wang Y; Zweifel BS; Koki AT; Masferrer JL
    Cancer Res; 2002 Feb; 62(3):625-31. PubMed ID: 11830509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
    Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer.
    Crane CH; Mason K; Janjan NA; Milas L
    Am J Clin Oncol; 2003 Aug; 26(4):S81-4. PubMed ID: 12902862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of COX-2 inhibition in breast cancer treatment and prevention.
    Arun B; Goss P
    Semin Oncol; 2004 Apr; 31(2 Suppl 7):22-9. PubMed ID: 15179621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2: a therapeutic target in angiogenesis.
    Iñiguez MA; Rodríguez A; Volpert OV; Fresno M; Redondo JM
    Trends Mol Med; 2003 Feb; 9(2):73-8. PubMed ID: 12615041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 inhibition and lung cancer.
    Sandler AB; Dubinett SM
    Semin Oncol; 2004 Apr; 31(2 Suppl 7):45-52. PubMed ID: 15179623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.